.
Wissen schafft Vertrauen
Systematische Literaturrecherche und Metaanalyse
Overview on Defocus Incorporated Multiple Segments Lenses: A Novel Perspective in Myopia Progression Management
Lesen Sie mehrEffectiveness of peripheral defocus spectacle lenses in myopia control: a Meta-analysis and systematic review
Lesen Sie mehrInterventions for myopia control in children: a living systematic review and network meta‐analysis. Cochrane Database of Systematic Reviews 2023
Lesen Sie mehrRandomisierte kontrollierte Studie
Defocus Incorporated Multiple Segments (DIMS)spectacle lenses slow myopia progression: a 2-yearrandomised clinical trial
Lesen Sie mehrDefocus Incorporated Multiple Segments Spectacle Lenses Changed the Relative Peripheral Refraction: A 2-Year Randomized Clinical Trial
Lesen Sie mehrEffect of Defocus Incorporated Multiple Segments Spectacle Lens Wear on Visual Function in Myopic Chinese Children
Lesen Sie mehrKohortenstudien
Optical and imaging properties of a novel multi-segment spectacle lens designed to slow myopia progression
Lesen Sie mehrMyopia treatment and prophylaxis with defocus incorporated multiple segments spectacle lenses
Lesen Sie mehrThe Adaptation and Acceptance of Defocus Incorporated Multiple Segment Lens for Chinese Children
Lesen Sie mehrMyopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study
Lesen Sie mehrMyopia-correcting lenses decrease eye fatigue in a visual search task for both adolescents and adults
Lesen Sie mehrEvaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 Pandemic
Lesen Sie mehrVision tests on spectacle lenses and contact lenses for optical myopia correction: a pilot study
Lesen Sie mehrMyopia Control Effect Is Influenced by Baseline Relative Peripheral Refraction in Children Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses
Lesen Sie mehrModelling the refractive and imaging impact of multi-zone lenses utilized for myopia control in children’s eyes
Lesen Sie mehrOne-year Efficacy of the Defocus Incorporated Multiple Segment Lens in Chinese Myopic Children
Lesen Sie mehrMyopia control: short‑term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses—a retrospective study in European children
Lesen Sie mehrSynergistic effects of defocus‑incorporated multiple segments and atropine in slowing the progression of myopia
Lesen Sie mehrChanges in relative peripheral refraction in children who switched from single-vision lenses to Defocus Incorporated Multiple Segments lenses
Lesen Sie mehrThe Efficacy of Defocus Incorporated Multiple Segments Lenses in Slowing Myopia Progression
Lesen Sie mehrOptical characterization of two novel myopia control spectacle lenses
Lesen Sie mehrA comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/ Atropine
Lesen Sie mehrLong‑term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years
Lesen Sie mehrComparison of optical myopia control interventions: effect on peripheral image quality and vision
Lesen Sie mehrMultiple segment spectacle lenses for myopia control. Part 1: Optics
Lesen Sie mehrMultiple segment spectacle lenses for myopia control. Part 2: Impact on myopia progression
Lesen Sie mehrAssociation between choriocapillaris perfusion and axial elongation in children using defocus incorporated multiple segments (DIMS) spectacle lenses
Lesen Sie mehrSicherheit von Brillengläsern mit DIMS-Technologie und Atropin in der Kombinationstherapie der Myopieprogression
Lesen Sie mehrStudien in Tiermodellen
Graded Competing Regional Myopic and Hyperopic Defocus Produce Summated Emmetropization Set Points in Chick
Lesen Sie mehrThe Effects of Simultaneous Dual Focus Lenses on Refractive Development in Infant Monkeys
Lesen Sie mehrSimultaneous Defocus Integration during Refractive Development
Lesen Sie mehr„Gemeinsam können wir Myopie bei Kindern bekämpfen“
Hinweis:
MiYOSMART ist nicht in allen Ländern, einschließlich den USA, für die Myopiebehandlung zugelassen und derzeit nicht in allen Ländern, einschließlich den USA, erhältlich.